2024 Safety And Regulatory Compliance Trends And Predictions For Pharma and Biotech

Rapidly evolving technologies like artificial intelligence (AI), machine learning (ML), and natural language processing (NLP) are becoming the way forward for navigating pharmacovigilance (PV), safety, and regulatory needs. As they continue to offer new possibilities, pharma companies must identify how best to implement these innovative technologies in order to stay ahead of the curve and create greater efficiency throughout workflows. An integrated safety and technology partnership can be a crucial step to harnessing the possibilities of said tools.

In a recent panel discussion, IQVIA leaders, Archana Hegde, Senior Director of Integrated PV Solutions; Michelle Gyzen, Senior Director of Regulatory Affairs and Drug Development Solutions; Elisa Hummings, Senior Director and Head of Medical Information and Local AE Intake Services; Michele Denarie, Principal of Regulatory Affairs and Drug Development Solutions; and Simon Johns, Director of Medical Information and Marketed Product Safety, provided their insights into the safety and compliance trends on the horizon. Download the full article to read their insights and forecasts for the 2024 safety and regulatory climate.